Michael P. Weiner
Oprichter bij Abbratech, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Michael Egholm | M | 61 |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | - |
| Sean Mackay | M | 41 |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | - |
| Linda Stevens | F | - |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Abbratech, Inc. is a biotechnology company that focuses on precision antibodies. Abbratech is based in Branford, CT. The company offers services such as antigen and project design, recombinant antibody development, antibody optimization, and antibody production. Abbratech uses the best available in vivo and in vitro methods for antibody discovery and applies knowledge gained from the past 15 years of human genome sequencing and antibody engineering to produce high affinity and highly specific recombinant antibodies. The company was founded in 2020 by Michael P. Weiner, who has been the CEO since then. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Mike I. Sherman | M | - |
Affomix Corp.
 Affomix Corp. Pharmaceuticals: MajorHealth Technology Affomix Corp. was develops and commercializes antibody based products. The company was founded in 2008 and headquartered in Branford, CT. | - |
| Sherman Weissman | M | - |
Affomix Corp.
Affomix Corp. Pharmaceuticals: MajorHealth Technology Affomix Corp. was develops and commercializes antibody based products. The company was founded in 2008 and headquartered in Branford, CT. | - |
| Michael Snyder | M | - |
Affomix Corp.
Affomix Corp. Pharmaceuticals: MajorHealth Technology Affomix Corp. was develops and commercializes antibody based products. The company was founded in 2008 and headquartered in Branford, CT. | - |
| Janet E. Verney | F | - |
Affomix Corp.
Affomix Corp. Pharmaceuticals: MajorHealth Technology Affomix Corp. was develops and commercializes antibody based products. The company was founded in 2008 and headquartered in Branford, CT. | - |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 7 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Michael P. Weiner
- Persoonlijk netwerk
